Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13469 | 771 | 37.5 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3021 | 2041 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THROMBOCYTOSIS | Author keyword | 15 | 17% | 10% | 80 |
2 | TCIPA | Author keyword | 12 | 86% | 1% | 6 |
3 | TUMOR CELL INDUCED PLATELET AGGREGATION | Author keyword | 4 | 75% | 0% | 3 |
4 | PREOPERATIVE PLATELET COUNT | Author keyword | 3 | 100% | 0% | 3 |
5 | HISTOL EMBRIOL GENET | Address | 2 | 67% | 0% | 2 |
6 | LODGEMENT | Author keyword | 2 | 67% | 0% | 2 |
7 | PL SHUPIK KYIV MED POST EDUC | Address | 2 | 67% | 0% | 2 |
8 | PLATELET MEGAKARYOCYTE GRP | Address | 1 | 100% | 0% | 2 |
9 | ARG GLY ASP CONTAINING PEPTIDE | Author keyword | 1 | 40% | 0% | 2 |
10 | PLATELET AGONISTS | Author keyword | 1 | 27% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THROMBOCYTOSIS | 15 | 17% | 10% | 80 | Search THROMBOCYTOSIS | Search THROMBOCYTOSIS |
2 | TCIPA | 12 | 86% | 1% | 6 | Search TCIPA | Search TCIPA |
3 | TUMOR CELL INDUCED PLATELET AGGREGATION | 4 | 75% | 0% | 3 | Search TUMOR+CELL+INDUCED+PLATELET+AGGREGATION | Search TUMOR+CELL+INDUCED+PLATELET+AGGREGATION |
4 | PREOPERATIVE PLATELET COUNT | 3 | 100% | 0% | 3 | Search PREOPERATIVE+PLATELET+COUNT | Search PREOPERATIVE+PLATELET+COUNT |
5 | LODGEMENT | 2 | 67% | 0% | 2 | Search LODGEMENT | Search LODGEMENT |
6 | ARG GLY ASP CONTAINING PEPTIDE | 1 | 40% | 0% | 2 | Search ARG+GLY+ASP+CONTAINING+PEPTIDE | Search ARG+GLY+ASP+CONTAINING+PEPTIDE |
7 | PLATELET AGONISTS | 1 | 27% | 0% | 3 | Search PLATELET+AGONISTS | Search PLATELET+AGONISTS |
8 | CICAPROST | 1 | 13% | 1% | 5 | Search CICAPROST | Search CICAPROST |
9 | ALPHA GRANULE | 1 | 16% | 1% | 4 | Search ALPHA+GRANULE | Search ALPHA+GRANULE |
10 | CALCIUM NADROPARIN | 1 | 50% | 0% | 1 | Search CALCIUM+NADROPARIN | Search CALCIUM+NADROPARIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRETREATMENT THROMBOCYTOSIS | 23 | 100% | 1% | 10 |
2 | THROMBOCYTOSIS | 13 | 18% | 9% | 66 |
3 | IIIA LIKE GLYCOPROTEINS | 9 | 83% | 1% | 5 |
4 | AGGREGATING ACTIVITIES | 8 | 100% | 1% | 5 |
5 | EXPERIMENTAL LUNG METASTASIS | 7 | 53% | 1% | 9 |
6 | AGGREGATING ACTIVITY | 7 | 67% | 1% | 6 |
7 | IRGPIIB IIIA | 6 | 80% | 1% | 4 |
8 | GLYCOPROTEINS IB | 6 | 71% | 1% | 5 |
9 | PREOPERATIVE THROMBOCYTOSIS | 5 | 55% | 1% | 6 |
10 | TUMOR CELL PLATELET | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer | 2014 | 14 | 96 | 48% |
Contribution of platelets to tumour metastasis | 2011 | 206 | 157 | 26% |
Platelets in cancer and thrombosis | 2014 | 11 | 85 | 36% |
Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation | 2004 | 94 | 116 | 59% |
The platelet contribution to cancer progression | 2011 | 89 | 158 | 42% |
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells | 2010 | 83 | 95 | 31% |
Tumor-platelet interaction in solid tumors | 2012 | 55 | 158 | 30% |
The functional role of platelets in the regulation of angiogenesis | 2015 | 1 | 178 | 20% |
Endothelium and cancer metastasis: Perspectives for antimetastatic therapy | 2015 | 1 | 95 | 19% |
Platelets and cancer | 2002 | 132 | 57 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HISTOL EMBRIOL GENET | 2 | 67% | 0.3% | 2 |
2 | PL SHUPIK KYIV MED POST EDUC | 2 | 67% | 0.3% | 2 |
3 | PLATELET MEGAKARYOCYTE GRP | 1 | 100% | 0.3% | 2 |
4 | SECT CARDIOVASC PHARMACOL SCI | 1 | 33% | 0.3% | 2 |
5 | AFFILIATED NORTH CHINA PETR BUR GEN HOSP | 1 | 50% | 0.1% | 1 |
6 | DIPARTIMENTO MED INTERNA TER IA | 1 | 50% | 0.1% | 1 |
7 | DOCTORATE PROGRAMM | 1 | 50% | 0.1% | 1 |
8 | EXPT KARDIOL | 1 | 50% | 0.1% | 1 |
9 | FLOATING HOSP CHILDREN MED | 1 | 50% | 0.1% | 1 |
10 | GYNECOL ONCOLGEFFEN MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197419 | CANCER PROCOAGULANT//TISSUE FACTOR//CANCER ASSOCIATED THROMBOSIS |
2 | 0.0000156359 | PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR |
3 | 0.0000092735 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
4 | 0.0000079745 | INVASION & METASTASIS//CLINICAL & EXPERIMENTAL METASTASIS//ND2001 |
5 | 0.0000078670 | PLATELET PROTEOME//EFS AUVERGNE LOIRE//SECT CARDIOIMMUNOL |
6 | 0.0000071256 | CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2 |
7 | 0.0000062955 | DISINTEGRIN//DISINTEGRINS//ECHISTATIN |
8 | 0.0000055308 | G CSF PRODUCING TUMOR//LEUKEMOID REACTION//LEUKOCYTOSIS |
9 | 0.0000055156 | SERV 151Z2//PP 2A//STRITCH MED OTOLARYNGOL |
10 | 0.0000045821 | MED PHYSIOL UNIT//GAMMA LINOLENIC ACID//YORKSHIRE EXPT CANC MED |